Previous close | 37.36 |
Open | 37.12 |
Bid | 36.88 x 150000 |
Ask | 36.92 x 150000 |
Day's range | 36.92 - 37.18 |
52-week range | 36.00 - 53.20 |
Volume | |
Avg. volume | 5,658 |
Market cap | 208.391B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 7.28 |
EPS (TTM) | 5.07 |
Earnings date | 02 May 2023 |
Forward dividend & yield | 1.55 (4.17%) |
Ex-dividend date | 26 Jan 2023 |
1y target est | N/A |
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.
Whether it's bear markets, shifting legislation, or an unstable macroeconomic environment, there are plenty of reasons an otherwise-stable company might see its stock stumble temporarily. Pfizer's (NYSE: PFE) shares are down by 20.3% in the last 12 months, and if you're willing to hold on to them for the long run, this stock is a great option for buying on the dip to gain a passive income stream.